Why Illumina, Inc. (ILMN) Stock Rose 7.6% on Oct 5, 2026
What happened
Illumina rose 4.94% to $286.52, driven by positive momentum from strong Q2 earnings (revenue $1.09B, +4.8% YoY) and raised full-year EPS guidance announced Jul 8, 2026, per Yahoo Finance. Analyst upgrades from firms including UBS and Piper Sandler, plus continued institutional buying following S&P 500 inclusion, are sustaining bullish sentiment. Volume of 1.5M shares is running 0.61x average for this point in the session.
ILMN earnings on 2026-10-29 (consensus EPS estimate $1.36); track whether the company sustains the guidance beat trajectory or signals any deceleration in NovaSeq X adoption.
Other developments that session
Argent Capital Management LLC established new 14,634-share position in Illumina during Q3.
Frequently asked questions
Why did Illumina, Inc. (ILMN) stock rise on Oct 5, 2026?
Illumina rose 4.94% to $286.52, driven by positive momentum from strong Q2 earnings (revenue $1.09B, +4.8% YoY) and raised full-year EPS guidance announced Jul 8, 2026, per Yahoo Finance. Analyst upgrades from firms including UBS and Piper Sandler, plus continued institutional buying following S&P 500 inclusion, are sustaining bullish sentiment. Volume of 1.5M shares is running 0.61x average for this point in the session.
How much did ILMN stock rise on Oct 5, 2026?
ILMN rose 7.6% during the Oct 5, 2026 trading session.